Cargando…

PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma

OBJECTIVES: There is a little evidence for the TRH test criteria in the diagnosis of Central Hypothyroidism (CeH). Therefore, we investigated the significance of the TRH test for Central Hypothyroidism due to Non-Functional Pituitary Adenoma. METHODS: 107 cases of Non-functional pituitary adenoma (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Buyandalai, Battsetseg, Takamizawa, Tetsuya, Horiguchi, Kazuhiko, Yoshioka, Masayuki, Nishikido, Ayaka, Toki, Akiko, Ishida, Emi, Yoshino, Satoshi, Matsumoto, Shunichi, Yamada, Eijiro, Ozawa, Atsushi, Yamaguchi, Rei, Tosaka, Masahiko, Yamada, Shozo, Yamada, Masanobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625588/
http://dx.doi.org/10.1210/jendso/bvac150.1669
_version_ 1784822536106672128
author Buyandalai, Battsetseg
Takamizawa, Tetsuya
Horiguchi, Kazuhiko
Yoshioka, Masayuki
Nishikido, Ayaka
Toki, Akiko
Ishida, Emi
Yoshino, Satoshi
Matsumoto, Shunichi
Yamada, Eijiro
Ozawa, Atsushi
Yamaguchi, Rei
Tosaka, Masahiko
Yamada, Shozo
Yamada, Masanobu
author_facet Buyandalai, Battsetseg
Takamizawa, Tetsuya
Horiguchi, Kazuhiko
Yoshioka, Masayuki
Nishikido, Ayaka
Toki, Akiko
Ishida, Emi
Yoshino, Satoshi
Matsumoto, Shunichi
Yamada, Eijiro
Ozawa, Atsushi
Yamaguchi, Rei
Tosaka, Masahiko
Yamada, Shozo
Yamada, Masanobu
author_sort Buyandalai, Battsetseg
collection PubMed
description OBJECTIVES: There is a little evidence for the TRH test criteria in the diagnosis of Central Hypothyroidism (CeH). Therefore, we investigated the significance of the TRH test for Central Hypothyroidism due to Non-Functional Pituitary Adenoma. METHODS: 107 cases of Non-functional pituitary adenoma (NFPA) in Gunma University Hospital Neurosurgery and Toranomon Hospital Intercerebral Pituitary Surgery, between 2007 to 2020 are studied. Subjects divided into CeH group (n = 19) with FT4 below the reference value and a normal group (n = 88). Serum TSH level was determined before (basal-TSH value) and 30, 60, 120 minutes after TRH administration. Peak-TSH value, delayed and prolonged responses were analyzed. A peak-TSH occurring at 60 minutes or later was considered as a delayed response. If 120-minutes TSH value to peak-TSH value ratio is equal to or higher than 0.6 was considered as a prolonged response. RESULTS: The basal-TSH was higher in the CeH group than in the normal group (median 2.7 vs. 1.5μIU/mL) (p <0.01). There was no difference between two groups, in both 30-minute value and the peak value. Delayed response occurred in 10/19 (53%) in the CeH group, and 18/88 (20%) in the normal group (p < 0.01). Prolonged response occurred at a higher rate of 15/19 (79%) in the CeH group, while in 23/88 (26%) in the normal group (p <0.01). AUC was maximum when prolonged response (120-minute value to peak value ratio) is equal to or lower than 0.65. CONCLUSION: In central hypothyroidism due to Non-Functional Pituitary Adenoma, the basal-TSH value does not usually decrease, but rather be higher value within the reference range. 30-minute value or peak value was not useful in diagnosis, yet the prolonged response was more significant. Central Hypothyroidism in Non-Functional Pituitary Adenoma, can be diagnosed with sensitivity of 79% and specificity of 78% when the 120-minute value to peak value ratio is equal to or lower than 0.65. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m.
format Online
Article
Text
id pubmed-9625588
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96255882022-11-14 PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma Buyandalai, Battsetseg Takamizawa, Tetsuya Horiguchi, Kazuhiko Yoshioka, Masayuki Nishikido, Ayaka Toki, Akiko Ishida, Emi Yoshino, Satoshi Matsumoto, Shunichi Yamada, Eijiro Ozawa, Atsushi Yamaguchi, Rei Tosaka, Masahiko Yamada, Shozo Yamada, Masanobu J Endocr Soc Thyroid OBJECTIVES: There is a little evidence for the TRH test criteria in the diagnosis of Central Hypothyroidism (CeH). Therefore, we investigated the significance of the TRH test for Central Hypothyroidism due to Non-Functional Pituitary Adenoma. METHODS: 107 cases of Non-functional pituitary adenoma (NFPA) in Gunma University Hospital Neurosurgery and Toranomon Hospital Intercerebral Pituitary Surgery, between 2007 to 2020 are studied. Subjects divided into CeH group (n = 19) with FT4 below the reference value and a normal group (n = 88). Serum TSH level was determined before (basal-TSH value) and 30, 60, 120 minutes after TRH administration. Peak-TSH value, delayed and prolonged responses were analyzed. A peak-TSH occurring at 60 minutes or later was considered as a delayed response. If 120-minutes TSH value to peak-TSH value ratio is equal to or higher than 0.6 was considered as a prolonged response. RESULTS: The basal-TSH was higher in the CeH group than in the normal group (median 2.7 vs. 1.5μIU/mL) (p <0.01). There was no difference between two groups, in both 30-minute value and the peak value. Delayed response occurred in 10/19 (53%) in the CeH group, and 18/88 (20%) in the normal group (p < 0.01). Prolonged response occurred at a higher rate of 15/19 (79%) in the CeH group, while in 23/88 (26%) in the normal group (p <0.01). AUC was maximum when prolonged response (120-minute value to peak value ratio) is equal to or lower than 0.65. CONCLUSION: In central hypothyroidism due to Non-Functional Pituitary Adenoma, the basal-TSH value does not usually decrease, but rather be higher value within the reference range. 30-minute value or peak value was not useful in diagnosis, yet the prolonged response was more significant. Central Hypothyroidism in Non-Functional Pituitary Adenoma, can be diagnosed with sensitivity of 79% and specificity of 78% when the 120-minute value to peak value ratio is equal to or lower than 0.65. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9625588/ http://dx.doi.org/10.1210/jendso/bvac150.1669 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Thyroid
Buyandalai, Battsetseg
Takamizawa, Tetsuya
Horiguchi, Kazuhiko
Yoshioka, Masayuki
Nishikido, Ayaka
Toki, Akiko
Ishida, Emi
Yoshino, Satoshi
Matsumoto, Shunichi
Yamada, Eijiro
Ozawa, Atsushi
Yamaguchi, Rei
Tosaka, Masahiko
Yamada, Shozo
Yamada, Masanobu
PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma
title PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma
title_full PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma
title_fullStr PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma
title_full_unstemmed PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma
title_short PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma
title_sort psat251 examination of trh test in central hypothyroidism due to non-functional pituitary adenoma
topic Thyroid
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625588/
http://dx.doi.org/10.1210/jendso/bvac150.1669
work_keys_str_mv AT buyandalaibattsetseg psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT takamizawatetsuya psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT horiguchikazuhiko psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT yoshiokamasayuki psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT nishikidoayaka psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT tokiakiko psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT ishidaemi psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT yoshinosatoshi psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT matsumotoshunichi psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT yamadaeijiro psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT ozawaatsushi psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT yamaguchirei psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT tosakamasahiko psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT yamadashozo psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma
AT yamadamasanobu psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma